2017
DOI: 10.1016/j.jmii.2016.08.008
|View full text |Cite
|
Sign up to set email alerts
|

Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms

Abstract: Third-generation cephalosporins effectively treated CoUTIs. However, patients with nasogastric tube retention more commonly experienced cephalosporin resistance. Cefepime, imipenem, and amikacin may be used in patients with higher antimicrobial resistance. In selected patients, cefazolin may still be an adequate drug of choice for CoUTIs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
19
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(22 citation statements)
references
References 11 publications
3
19
0
Order By: Relevance
“…In this study, nearly half of the isolates were resistant to the majority of the tested antimicrobials, with 34.6% of the strains demonstrating MDR, which is in agreement with previous studies conducted in different regions of Turkey 12,24 . In accordance with the results of the study, 67.3%, 50.9%, 45.1%, 45.1%, 38.7%, 36.6%, 35.9%, 35.9%, and 32.7% were resistant to ampicillin, amoxicillin-clavulanic acid, cefazolin, trimethoprimsulfamethoxazole, cefuroxime, ceftriaxone, ciprofloxacin, cefepime, and norfloxacin, respectively, which are the first-line therapeutic agents used for UTI treatment 23,25 . These resistance rates may be explained by the frequent prescription of these antimicrobials in empirical treatment of UTIs.…”
Section: Determination Of Antimicrobial Resistance and Virulencesupporting
confidence: 89%
See 1 more Smart Citation
“…In this study, nearly half of the isolates were resistant to the majority of the tested antimicrobials, with 34.6% of the strains demonstrating MDR, which is in agreement with previous studies conducted in different regions of Turkey 12,24 . In accordance with the results of the study, 67.3%, 50.9%, 45.1%, 45.1%, 38.7%, 36.6%, 35.9%, 35.9%, and 32.7% were resistant to ampicillin, amoxicillin-clavulanic acid, cefazolin, trimethoprimsulfamethoxazole, cefuroxime, ceftriaxone, ciprofloxacin, cefepime, and norfloxacin, respectively, which are the first-line therapeutic agents used for UTI treatment 23,25 . These resistance rates may be explained by the frequent prescription of these antimicrobials in empirical treatment of UTIs.…”
Section: Determination Of Antimicrobial Resistance and Virulencesupporting
confidence: 89%
“…Increased antimicrobial resistance rates, particularly for beta-lactams, sulfamethoxazole-trimethoprim, third generation cephalosporins, and fluoroquinolones, has led to challenges in clinical practice 23 . In this study, nearly half of the isolates were resistant to the majority of the tested antimicrobials, with 34.6% of the strains demonstrating MDR, which is in agreement with previous studies conducted in different regions of Turkey 12,24 .…”
Section: Determination Of Antimicrobial Resistance and Virulencementioning
confidence: 99%
“…14 UTI may be complicated by AKI. 3,15 Older age, diabetes, upper UTI, poor base-line renal functions are reported risk factors for AKI in UTI. 15 In our study, we evaluated ESBL-positivity of organisms causing UTI as risk factor for AKI.…”
Section: Discussionmentioning
confidence: 99%
“…However, our cases were resistant to cotrimoxazole/trimethoprim in contrast to his series where cotrimoxazole was found to be second drug of choice. 11 Chih-C C et al also reported E.coli responsible for 54.5% cases of UTI and about 13.1% cases. He reported Amikacin and Gentamycin as the drug of choice.…”
Section: Discussionmentioning
confidence: 92%